September 21, 2023
OXFORD BIOMEDICA AND INSTITUT MERIEUX ENTER INTO EXCLUSIVE NEGOTIATIONS FOR THE PROPOSED ACQUISITION OF ABL EUROPE
September 18, 2023
ASEPTIC PROCESS OF VIRAL VECTOR-BASED VACCINES – KEY ASPECTS TO CONSIDER BEFORE CLINICAL MANUFACTURING
August 29, 2023
PROCESS CHARACTERIZATION OF VIRAL VECTORS: APPROACH IN CDMO CONTEXT
July 18, 2023